Thyroid disease

A nationwide registry‐based observational study of thyroid disease incidence in the Faroe Islands

Clin Endocrinol (Oxf)Published Registry-based observational study

Authors' conclusion

Considering the decrease in iodine nutrition levels over the past decades, we were surprised by the high incidence of autoimmune thyroid disease. The findings highlight the need for continuous monitoring of thyroid disease occurrence in coastal areas of the North Atlantic Ocean.

Study context

Population
All adult Faroese individuals, Faroe Islands, 2006–2018; incident thyroid disease identified from GP and hospital health recordsdiagnosed with thyroid disease
Participants
1,152 individuals
Outcome
Standardised incidence rates of thyroid diseases, including subtypes
Methodological detailsnationwide, 10-year study period, Validation using multiple data sources; rates standardised to population data from the middle of the study period
  • Nationwide
  • 10-year study period
  • Validation using multiple data sources; rates standardised to population data from the middle of the study period

Main finding

As reported in the abstract

Standardised incidence rates per 100,000 person-years

Hyperthyroidism, per 100,000 person-years

55

Hypothyroidism, per 100,000 person-years

112

Observational data: associations, not effects.

Further findings

Causes of thyroid disease

Hashimoto's thyroiditis was the dominant cause of hypothyroidism; Graves' disease the leading cause of hyperthyroidism

Hypothyroidism incidence by age

Incidence of hypothyroidism increases with age

Trend over time

Decreasing trend over time for both hypothyroidism and hyperthyroidism

Original publication

A nationwide registry‐based observational study of thyroid disease incidence in the Faroe Islands. Clin Endocrinol (Oxf). Published 13 March 2024. doi:10.1111/cen.15050

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.